Vaccines have proved a vital lifeline in the fightback against COVID-19, with our collective safety largely reliant on the efficacy of vaccines developed by pharmaceuticals companies. For the pharmaceutical sector, as in the healthcare sector, innovation has been the byword for the pandemic response. But what have been the lessons? And how might the NHS and pharmaceutical sector work in partnership to confront pressing healthcare challenges?
Uday Bose, country managing director and head of human Pharma at Boehringer Ingelheim UK & Ireland, sits down with Matthew Taylor to consider the issues. Uday, who also chairs the European Medicines Group, also explores how pharmaceuticals are increasingly working with patients and taking account of patient experience.
Hosted on Acast. See acast.com/privacy for more information.
Health On The Line